On behalf of everyone at G2 Intelligence, thank you to all the attendees, sponsors, and a world-class faculty of molecular experts and laboratory business leaders who attended MDx NEXT: Molecular Diagnostics at the Crossroads: Innovation in the Face of a Reimbursement Crunch.
We trust that this year’s agenda provided timely insights into the key operational and business considerations of genomic medicine, including what’s happening now — and what’s next — especially around realizing molecular diagnostics as a driver of growth, despite an overhaul of the established “code-stacking” reimbursement system and other obstacles that have place MDx at a critical juncture.
Special thanks to our distinguished speakers for taking time from their busy schedules to share their expertise and thoroughly cover every aspect of evolving MDx technologies, business challenges and opportunities, legal issues, day-to-day concerns, and attitudes toward molecular diagnostics as it continues to evolve in ways that are bringing new challenges and opportunities for labs.
Once again, our thanks to everyone who took part in G2’s annual MDx NEXT molecular diagnostics conference, the must-attend event for:
We’re already in the early planning stages of G2’s tenth annual MDx NEXT. Check back for more details on the 2015 conference!
Conference Wi-Fi compliments of: